ARCT

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Arcturus Therapeutics Holdings Inc

NASDAQ | ARCT

18.95

USD

$0.00

(

0.00%

)

At Close (As of Oct 10, 2025)

$514.58M

Market Cap

-

P/E Ratio

-2.22

EPS

$23.59

52 Week High

$8.03

52 Week Low

HEALTHCARE

Sector

ARCT Chart

Recent Chart
Price Action

ARCT Technicals

Tags:

ARCT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $135M
Total Revenue $138M
Cost Of Revenue $3.5M
Costof Goods And Services Sold $3.5M
Operating Income -$96M
Selling General And Administrative $53M
Research And Development $195M
Operating Expenses $174M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.5M
Income Before Tax -$81M
Income Tax Expense -$4K
Interest And Debt Expense -
Net Income From Continuing Operations -$81M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$77M
Net Income -$81M

Revenue & Profitability

Earnings Performance

ARCT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $344M
Total Current Assets $306M
Cash And Cash Equivalents At Carrying Value $237M
Cash And Short Term Investments $237M
Inventory -
Current Net Receivables $4M
Total Non Current Assets $38M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $65M
Other Non Current Assets -
Total Liabilities $103M
Total Current Liabilities $65M
Current Accounts Payable $7.2M
Deferred Revenue -
Current Debt -
Short Term Debt $7.1M
Total Non Current Liabilities $38M
Capital Lease Obligations $29M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $29M
Other Current Liabilities $29M
Other Non Current Liabilities -
Total Shareholder Equity $241M
Treasury Stock -
Retained Earnings -$449M
Common Stock $27K
Common Stock Shares Outstanding $27M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$60M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3.5M
Capital Expenditures $648K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$648K
Cashflow From Financing $5.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$81M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $135M
Total Revenue $138M
Cost Of Revenue $3.5M
Costof Goods And Services Sold $3.5M
Operating Income -$96M
Selling General And Administrative $53M
Research And Development $195M
Operating Expenses $174M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $3.5M
Income Before Tax -$81M
Income Tax Expense -$4K
Interest And Debt Expense -
Net Income From Continuing Operations -$81M
Comprehensive Income Net Of Tax -
Ebit -$81M
Ebitda -$77M
Net Income -$81M

ARCT News

ARCT Profile

Arcturus Therapeutics Holdings Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Arcturus Therapeutics Holdings Inc. is a biopharmaceutical company based in San Diego, California, specializing in RNA therapeutics for the treatment of liver and respiratory diseases. With a strong emphasis on developing innovative therapies, Arcturus leverages its proprietary RNA delivery platform to create novel drug candidates aimed at addressing unmet medical needs. The company is at the forefront of the rapidly evolving biotechnology sector, positioning itself as a key player in the development of advanced RNA-based treatments that have the potential to transform patient outcomes.

VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVTS
+23.51%
$10.16
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
JOBY
+2.61%
$16.70
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
PFE
-0.30%
$24.70
RR
+7.85%
$6.38
SOUN
+10.77%
$19.23
WBD
-3.22%
$17.10
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
IREN
+8.04%
$64.58
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
NAKA
-4.05%
$0.83
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
QUBT
+10.49%
$21.01
GDXD
-12.99%
$0.74
SNAP
+3.14%
$8.02
XCH
+119.76%
$1.81
T
-1.06%
$25.59
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
HOOD
+1.03%
$140.40
HPE
+2.76%
$25.07
PMAX
+75.28%
$4.54
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14
KDP
+3.02%
$26.60
RGTZ
-42.68%
$10.66
VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVTS
+23.51%
$10.16
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
JOBY
+2.61%
$16.70
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
PFE
-0.30%
$24.70
RR
+7.85%
$6.38
SOUN
+10.77%
$19.23
WBD
-3.22%
$17.10
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
IREN
+8.04%
$64.58
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
NAKA
-4.05%
$0.83
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
QUBT
+10.49%
$21.01
GDXD
-12.99%
$0.74
SNAP
+3.14%
$8.02
XCH
+119.76%
$1.81
T
-1.06%
$25.59
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
HOOD
+1.03%
$140.40
HPE
+2.76%
$25.07
PMAX
+75.28%
$4.54
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14
KDP
+3.02%
$26.60
RGTZ
-42.68%
$10.66
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.